ACI-Boston SyllabusClick here for for access to the ACI Boston program book.This program has already taken place, to find information on upcoming programs, please click here. Program AgendaOct. 10, 2019 ProgramUpdated credit hours for this program are listed below*.Click here for more detailed accreditation information and program objectives. Presentations include time for Audience Response System (ARS)-assisted audience interaction as well as general question and answer time.
2:30 – 3:30 p.m.
Session I: Introduction to Cancer Immunotherapy
3:25 – 3:30 p.m.
Welcome, Introduction, SITC Resources
3:30 – 4 p.m.
Basic Principles of Cancer ImmunotherapyRyan J. Sullivan, MD – Massachusetts General Hospital
4 – 4:05 p.m.
Session II: Immunotherapy in Practice
4:05 – 4:40 p.m.
Immunotherapy for the Treatment of Skin CancersElizabeth Buchbinder, MD – Dana-Farber Cancer Institute
Immunotherapy for the Treatment of Lung CancerDeepa Rangachari, MD – Beth Israel Deaconess Medical Center
4:40 – 4:45 p.m.
4:45 – 5:20 p.m.
Immunotherapy for the Treatment of Head and Neck CancersGlenn J. Hanna, MD – Dana-Farber Cancer Institute
Immunotherapy for the Treatment of Genitourinary MalignanciesJoaquim Bellmunt, MD, PhD – Beth Israel Deaconess Medical Center
5:20 – 5:25 p.m.
5:25 – 6:00 p.m.
Immunotherapy for the Treatment of Hematologic MalignanciesMyrna Nahas, MD – Beth Israel Deaconess Medical Center
Immunotherapy for the Treatment of Additional Solid Tumors - HepatocellularOsama E. Rahma, MD – Dana-Farber Cancer Institute
6 – 6:30 p.m.
Session III: Immunotherapy Challenges and Beyond
6:30 – 7:10 p.m.
Toxicity ManagementVirginia Seery, MSN, RN, ANP-BC – Beth Israel Deaconess Medical Center
7:10 – 7:40 p.m.
Practical Barriers in Cancer Immunotherapy TreatmentJennifer Espiritu, PharmD, BCOP – Beth Israel Deaconess Medical Center
7:40 – 7:55 p.m.
Break/Conclusion of the CME/CE Program
Non-CME/CE Program Session
7:55 – 8:30 p.m.
What's next for cancer immunotherapy? Howard L. Kaufman, MD, FACS – Replimune Group Inc.
8:30 – 8:35 p.m.
*Accreditation Information for ACI - Boston
Joint Accreditation Statement
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Pharmacy Education
Postgraduate Institute of Medicine designates this continuing education activity for 3.5 contact hours (0.35 CEUs) of the Accreditation Council for Pharmacy Education. University Activity Number: JA4008162-9999-19-895-L01-PType of Activity: ApplicationContinuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
Download PDF Flyer
Courtyard Boston Downtown275 Tremont StreetBoston, MA 02116
Participation in this free, CME-, CPE-, CNE- and MOC-certified online pre-program course is strongly recommended as it contains information that will not be covered at the program. This updated, interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program.Click here to access the course.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org